Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

One Nucleus Signs Agreement with Bionow to Expand Access to One Nucleus Preferred Suppliers

Published: Tuesday, January 04, 2011
Last Updated: Tuesday, January 04, 2011
Bookmark and Share
The Collaboration will give members access to greater benefits.

One Nucleus is delighted to announce that an agreement has been signed with Bionow for their Premium Members to have access to the One Nucleus Preferred Suppliers through the One Nucleus Purchasing Consortium Scheme. This agreement took effect on 1 January 2011.
 
The One Nucleus Purchasing Consortium has an annual spend of over £6 million with its 8 Preferred Suppliers and over 70 One Nucleus Gold Members. The consortium aims to utilise the buying volume of member companies to negotiate and promote Preferred Supply Agreements. The aim is not only to provide bottom line cost savings for members but to also provide added value services that would not normally be available to One Nucleus member companies on an individual basis.
 
Richard Dickinson, Director of Specialist Services at One Nucleus said “One Nucleus and Bionow are working together in partnership to leverage the combined buying power in a way that benefits all our member companies”.
 
Geoff Davison, CEO of Bionow said ”I am delighted that Bionow is able to leverage this significant saving power for our member companies. By accessing this scheme our members will be able to make the savings that will allow them to compete more effectively, significantly strengthening the UK offer in life sciences.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

One Nucleus Purchasing Scheme: New Deal for Members for Laboratory Products
Nucleus is delighted to announce that Fisher Scientific has been awarded the contract for laboratory supplies under its Purchasing Consortium Scheme (preferred supplier agreement - PSA).
Wednesday, December 08, 2010
Scientific News
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Lab-on-a-Chip for Detecting Glucose
By integrating microfluidic chips with fiber optic biosensors, researchers in China are creating ultrasensitive lab-on-a-chip devices to detect glucose levels.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
Parsortix Demonstrates Benefits Over Marker-Based Systems
Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumour cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis.
Experimental Therapy For Brain Cancer Could Prevent Drug Resistance
Information from penny-sized microfluidic chips allowed researchers to anticipate resistance to cancer treatment.
3D Printing of Lego Fluidics
Study shows how 3D printing can open up microfluidic technology to a wider audience.
New Method to Preserve Device to Monitor HIV Treatment
Inspired by pregnancy tests, scientists have developed a method to store microfluidic devices for months without refrigeration, giving developing countries an inexpensive and reliable way to treat patients.
Migration Creates Cancer Cell Vulnerabilities
Scientists found that migration can damage cancer cells’ nuclei and DNA, requiring repairs for their survival. The results may open new avenues for targeting metastatic cancer.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!